Heart Disease Clinical Trials in Colorado

Showing 261-280 of 366 trials

Vascular Inflammation in Psoriasis - Extension Study

NCT01866592

VIP-E is a one-arm, open-label, 40-52 week extension study to continue or cross over subjects of the VIP study (# 814278) to active drug (adalimumab) to determine if there is sustained improvement in vascular inflammation, lipid metabolism, and inflammatory markers. VIP-E extends VIP study procedures for 40-52 weeks including questionnaires, physical exams, blood and urine samples, lab tests, one additional FDG-PET/CT scan, and adalimumab injections following FDA-approved psoriasis treatment regimen.

PsoriasisCardiovascular Disease

University of Pennsylvania81 participantsStarted Apr 2013

Sacramento, California, United States • Denver, Colorado, United States • Bethesda, Maryland, United States +6 more locations

TERMINATEDNA50 miles

Cardiovascular Improvements With MV ASV Therapy in Heart Failure

NCT01953874

The aim of the study is to compare the effects of MV targeted ASV in addition to optimized medical therapy versus optimized medical therapy alone at 6 months in patients with acute decompensated HF. The study will also assess changes in functional parameters, biomarkers, quality of life (QOL), and sleep.

Acute Decompensated Heart FailureSleep Disordered Breathing

ResMed126 participantsStarted Dec 2013

Huntsville, Alabama, United States • Los Angeles, California, United States • Denver, Colorado, United States +12 more locations

Vascular Inflammation in Psoriasis - Extension Study

Cardiovascular Improvements With MV ASV Therapy in Heart Failure

Heart Disease Trials in Other Cities

Pexelizumab in Patients Undergoing Coronary Artery Bypass Grafting With Cardiopulmonary Bypass (PRIMO-CABG II)

Collaborative Care to Alleviate Symptoms and Adjust to Illness in Chronic Heart Failure (CASA) Trial

Naltrexone/Bupropion Cardiovascular Outcomes Study

Effect of Pexelizumab on All-Cause Mortality and Myocardial Infarction in Patients Undergoing Coronary Artery Bypass Graft Surgery With Cardio-Pulmonary Bypass

Targeting Acute Congestion With Tolvaptan in Congestive Heart Failure

Echocardiography Guided Cardiac Resynchronization Therapy (EchoCRT)

Functional Impact of GLP-1 for Heart Failure Treatment (FIGHT)

Extension Phase of the Chronicle® Offers Management to Patients With Advanced Signs & Symptoms of Heart Failure Study

Folic Acid for Vascular Outcome Reduction In Transplantation (FAVORIT)

Statin Choice Decision Aid Implementation First Phase

Long-Term rIsk, Clinical manaGement and Healthcare Resource Utilization of Stable CAD in Post MI Patients

NAVISTAR® THERMOCOOL® Catheter for the Radiofrequency Ablation of Symptomatic Paroxysmal Atrial Fibrillation

Combination Therapy Compared With Single-Drug Therapy in Patients With Cardiac Diseases

Efficacy of Remodulin in Adults With Congenital Heart Disease (ACHD) and Pulmonary Hypertension

Educational Program for Various Health Literacy Levels to Improve the Health of Individuals With Heart Failure

Get Going: Accelerometer-Based Intervention to Promote Physical Activity in Frail Older Adults

Prospective Multicenter Registry On RadiaTion Dose Estimates Of Cardiac CT AngIOgraphy IN Daily Practice in 2017

Pharmacist-led Group Medical Visits to Help With Diabetes Management

Other Conditions in Colorado